Background and objectives
Peginterferon-α treatment exhibits low rates of the serological conversion rate of hepatitis B e antigen (HBeAg) and the negative conversion rate of hepatitis B virus (HBV) DNA, with significant…
Combination strategy may optimize interferon-based therapy for chronic hepatitis B
